Reduction in atherosclerotic lesion size in pigs by αVβ3 inhibitors is associated with inhibition of insulin-like growth factor-I-mediated signaling

Circulation Research

Volumn 85, Issue 11, 1999, Pages 1040-1045

  Nichols, Timothy C ^a   Du Laney, Tracey ^a   Zheng, Bo ^a   Bellinger, Dwight A ^b   Nickols, G Allen ^c   Engleman, Wayne ^c   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Monsanto/Searle Inc   (United States)

Author keywords

Arteriosclerosis; Disintegrin; Insulin; Signal transduction

Indexed keywords

DISINTEGRIN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SWINE; TARGET CELL;

EID: 0033607570     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.11.1040     Document Type: Article

References (36)

1. Schwartz SM, Reidy MA. O'Brien RM. Assessment of factors important in atherosclerotic occlusion and restrictions. Thromb Hemost. 1995;74:541-555.
2. Sanders M. Molecular and cellular concepts in atherosclerosis. Pharmacol Ther. 1994;61:109-153.
3. Clyman RI, Mauray F, Kramer RH. β1 and β3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix. Exp Cell Res. 1992;200:272-284.
4. Shatil SJ. Functional regulation of β3 integrins in hemostasis and vascular biology. Thromb Hemost. 1995;74:149-155.
5. Luscinskas FW, Lawler J. Integrins as dynamic regulators of vascular formation. FASEB J. 1994;8:929-938.
6. Liaw L, Skinner MD, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J Clin Invest. 1995;95:713-724.
7. Naito M, Hayasi T, Funaki C, Kuzuya M, Asai K, Kuzuya F. Vitroneclin-induced haptotaxis of vascular smooth muscle cells in vitro. Exp Cell Res. 1991;194:154-156.
8. Jones JI, Prevette T, Gockerman A, Clemmons DR. Ligand occupancy of the αVβ3 integrin is necessary for smooth muscle cell to migrate in response to insulin-like growth factor I. Proc Natl Acad Sci U S A. 1996;93:2482-2487.
9. Matsuno H, Stassen JM, Vermylen J, Deckmyn H. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 1994;4:2203-2206.
10. Choi ET, Engel L, Callow AD, Sun S, Trachtenberg J, Santoro S, Ryan US. Inhibition of neointimal hyperplasia by blocking αVβ3 integrin with a small peptide antagonist Open GRGDSPCA. J Vasc Surg. 1994;19:125-134.
11. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical stenosis: results at 6 months. Lancet. 1994;3431:881-886.
12. Horton MA, Taylor ML, Amett TR, Helfirch MH. Arg-gly-asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine absorption and cell spreading by osteoclasts. Exp Cell Res. 1991;195:368-375.
13. Scarborough RM, Rose JW, Naughton MA, Phillips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF. Characterization of the integrin specificities of disintegrins isolated from American Pit Viper venoms. J Biol Chem. 1993;268:1058-1065.
14. Brooks PC, Clark RA, Cheresh DA. Requirement of integrin αVβ3 for angiogenesis. Science. 1994;264:569-571.
15. Gockerman A, Clemmons DR. Porcine aortic smooth muscle cells secrete a serine protease for insulin like growth factor binding protein-2. Circ Res. 1995;76:514-521.
16. Zheng B, Clemmons DR. Blocking ligand occupancy of the αVβ3 integrin inhibits IGF-I signaling in vascular smooth muscle cells. Proc Natl Acad Sci U S A. 1998;95:11217-11222.
17. Miyamoto S, Teramoto H, Gutkind JS, Yamada KM. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J Cell Biol. 1996;135:1633-1642.
18. Schwartz MA, Ingber DE. Interpreting with integrins. Mol Biol Cell. 1994;5:389-393.
19. Klein S, Giancotti FG, Presta M, Albeda SM, Buck CA, Rifkin DB. Basic fibroblast growth factor modulates integrin expression in vesical vascular endothelial cells. Mol Biol Cell. 1993;4:973-982.
20. Clemmons DR, Horvitz G, Engleman W, Nichols T, Moralez A, Nickols GA. Synthetic αVβ3 antagonists inhibit insulin-like growth factor-I-stimulated smooth muscle cell migration and replication. Endocrinology. 1999;140:4616-4621.
21. Zheng B, Duan C, Clemmons DR. The effect of extracellular matrix protein on porcine smooth muscle cells insulin like growth factor binding protein-5 synthesis and responsiveness to IGF-I. J Biol Chem. 1998;273:8994-9000.
22. Hasler-Rapacz JO, Nichols TC, Griggs TR, Bellinger DA, Rapacz J. Familial and diet-induced hypercholesterolemia in swine: lipid, ApoB, and apoA-I concentrations and distributions in plasma and lipoprotein subtractions. Arterioscler Thromb. 1994;14:923-930.
23. Nichols TC, Bellinger DA, Davis KE, Koch GG, Reddick RL, Read MS, Rapacz J, Hester-Rapacz J, Brinkhous KM, Griggs TR. Porcine von Willebrand disease and atherosclerosis: influence of polymorphism apolipoprotein B100 genotype. Am J Pathol. 1992;140:403-415.
24. Nichols TC, Bellinger DA, Reddick RL, Koch GG, Sigman JL, Erickson G, du Laney T, Johnson T, Read MS, Griggs TR. von Willebrand factor does not influence atherogenesis in arteries subjected to altered shear stress. Arterioscler Thromb Vasc Biol. 1998;13:323-330.
25. Azrin MA, Michael JF, From DB, Pedersen CA, Cartun RW, Barry JJ, Bow LM, Waters DD, McKay RG. Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel coated balloons. Circulation. 1994;90:433-441.
26. Pytela R, Pierschbacher MD, Angravers S, Susuki S, Ruoslahti E. Arginine-glycine aspartic acid and lesion receptors. Methods Enzymol. 1987;144:475-489.
27. Engleman WV, Nichols GA, Ross FP, Horton MA, Griggs DW, Settle SL, Rimpinski PG, Teitlebaum SL. A peptidomimetic antagonist of the αVβ3 integrin inhibits nonrespiration and prevents osteoporosis in vivo. J Clin Invest. 1997;99:2284-2292.
28. Mould AP, Akiyama SK, Humphries MJ. Regulation of distinct α5β1 fibronectin interactions by divalent cations. J Biol Chem. 1995;270: 26270-26271.
29. Bodary SC, McLean JW. The integrin β1 subunit associates with the vitronectin receptor αV subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem. 1990;265:5938-5941.
30. Booth FG, Martin JF, Honey AC, Hasall DG, Beasley JE, Moncada S. Rapid development of atherosclerotic lesions in rabbit carotid artery induced by perivascular manipulation. Atherosclerosis. 1989;76:257-268.
31. Cercek B, Fishbein MC, Forrester JS, Helfant RH, Fagin JA. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res. 1990;66:1755-1760.
32. Grant MB, Wargovich TJ, Ellis EA, Caballero S, Mansour M, Pepine CJ. Localization of insulin like growth factor-I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. Circulation. 1994;89:1511-1517.
33. Wang J, Wen N, Witte DP, Chernausek SD, Nikiforov YE, Clemens TL, Sharifi B, Strauch AR, Fagin JA. Overexpression of IGFBP-4 in smooth muscle cells of transgenic mice through a smooth muscle α actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. Endocrinology: 1998;139:2605-2614.
34. Imai Y, Busby WH, Clark JB, Horvitz G, Rees C, Clemmons DR. Protease resistant IGFBP-5 inhibits actions of IGF-I on porcine smooth muscle cells. J Clin Invest. 1997;100:2596-2605.
35. Srivatsa SS, Fitzpatrick LA, Tsao PW, Reilly TM, Holmes DR, Schwartz RS, Mousa SA. Selective αVβ3 integrin blockade potently limits neointimal hypoplasia and lumen stenosis after deep coronary arterial stent injury. Cardiovasc Res. 1997;36:408-428.
36. Yue TL, McKenna PJ, Ohlstein EH, Farach-Carson MC, Butler WC, Johanson R, McDenitly P, Feuerstain GZ, Standel JM. Osteopontin stimulated vascular smooth muscle cell migration is mediated by β3 integrin. Exp Cell Res. 1994;214:459-464.